Release Date: 13/06/14 14:46 Summary: Letter to shareholders - extension of takeover offer Price Sensitive: No Download Document 284.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%